TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
27.71
-0.37 (-1.32%)
At close: Aug 18, 2025, 3:59 PM
27.55
-0.60%
Pre-market: Aug 19, 2025, 05:41 AM EDT
TG Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 132.14M | 179.89M | 195.82M | 82.91M | 75.48M | 92.93M | 229.16M | 97.01M | 61.47M | 102.3M | 109.86M | 147.07M | 185.68M | 298.89M | 326.51M | 401.71M | 471.51M |
Short-Term Investments | 144.1M | 131.11M | 145.22M | 134.34M | 134.31M | 124.58M | 78.26M | 47.9M | 78.24M | 59.37M | 66.08M | 48.64M | 47.52M | 15.88M | 30.34M | 41.75M | 52.33M |
Long-Term Investments | 3.21M | 2.11M | 2.42M | 2.24M | 2.61M | 1.28M | 1.28M | 1.28M | 1.28M | 12.4M | 21.77M | 36.08M | 47.47M | 35.53M | 24.55M | 12.76M | 1.26M |
Other Long-Term Assets | 2.04M | 2.07M | 2.11M | 2.15M | 1.36M | 1.42M | 2.88M | 3.01M | 3.09M | 1.27M | 1.27M | 1.27M | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
Receivables | 190.12M | 129.19M | 115.73M | 83.61M | 64.98M | 51.09M | 39.32M | 17.48M | 8.62M | n/a | n/a | 88K | 903K | 1.39M | 1.38M | 931K | 771K |
Inventory | 157.76M | 110.46M | 84.67M | 81.24M | 77.72M | 39.82M | 33.55M | 30.23M | 27.22M | n/a | n/a | -32.45M | 4.09M | -23.6M | -13.51M | -5.03M | 5.59M |
Other Current Assets | 20.39M | 15.72M | 32.63M | 7.05M | 8.1M | 5.34M | 12.08M | 15.95M | 4.46M | 2.36M | 2.95M | 3.14M | 4.02M | 2.88M | 2.5M | 2.95M | 4.8M |
Total Current Assets | 644.51M | 566.36M | 574.07M | 389.15M | 360.58M | 317.94M | 229.16M | 144.91M | 184.78M | 168.27M | 182.92M | 202.56M | 242.22M | 330.96M | 371.78M | 455.07M | 535.01M |
Property-Plant & Equipment | 6.93M | 7.15M | 7.41M | 7.66M | 7.97M | 8.14M | 8.27M | 8.47M | 8.69M | 10.82M | 11.13M | 10.96M | 11.28M | 11.07M | 11.3M | 11.52M | 11.63M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K | 799K |
Total Long-Term Assets | 12.18M | 11.33M | 11.95M | 12.06M | 12.74M | 11.64M | 11.95M | 12.28M | 12.57M | 25.3M | 34.97M | 49.11M | 60.81M | 48.66M | 37.91M | 26.33M | 13.69M |
Total Assets | 656.69M | 577.69M | 586.01M | 401.21M | 373.32M | 329.59M | 331.07M | 220.85M | 197.36M | 193.57M | 217.89M | 251.67M | 303.03M | 379.63M | 409.69M | 481.4M | 548.7M |
Account Payables | 133.93M | 58.3M | n/a | 93.47M | 87.27M | 38.47M | 39.74M | 62.95M | 57.09M | n/a | 29.73M | 37.22M | 48.37M | 51.29M | 44.7M | 40.23M | 42.84M |
Deferred Revenue | 18.38M | 12.21M | 9.09M | 3.37M | 3.37M | 300K | 6.9M | 229K | 267K | n/a | 343K | 381K | 419K | 457K | 495K | 533K | 571K |
Short-Term Debt | 874K | 661K | 1.23M | 1.31M | 1.38M | 1.45M | 1.48M | 1.51M | 1.55M | n/a | 1.62M | 1.48M | 1.49M | 2.41M | 17.47M | 24.66M | 31.66M |
Other Current Liabilities | 773K | 3.17M | 114.79M | 2.86M | 2.68M | 12.36M | 8.08M | 6.7M | 2.89M | 51.62M | 3.49M | 3.14M | 2.88M | 10.24M | 10.66M | 12.12M | 12.36M |
Total Current Liabilities | 160.21M | 90.68M | 125.11M | 108.66M | 99.68M | 53.72M | 57.68M | 72.67M | 63.08M | 53.2M | 36.45M | 43.33M | 54.66M | 65.38M | 87.66M | 87.55M | 92.49M |
Long-Term Debt | 244.73M | 244.43M | 244.16M | 102.54M | 101.33M | 100.12M | 9.52M | 9.8M | 10.08M | 71.14M | 70.04M | 68.95M | 67.25M | 66.79M | 10.02M | 10.19M | 10.35M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 89.39M | 87.89M | 86.42M | 305K | n/a | n/a | n/a | n/a | -10.02M | -10.19M | -10.35M |
Total Long-Term Liabilities | 259.19M | 264.65M | 268.74M | 114.97M | 113.53M | 115.36M | 108.62M | 107.73M | 106.85M | 81.78M | 80.96M | 79.31M | 77.99M | 77.09M | 10.52M | 10.72M | 10.92M |
Total Liabilities | 419.4M | 355.33M | 393.86M | 223.64M | 213.21M | 169.09M | 166.3M | 180.4M | 169.93M | 134.99M | 117.41M | 122.63M | 132.64M | 142.48M | 98.17M | 98.27M | 103.41M |
Total Debt | 254.58M | 254.38M | 253.81M | 112.54M | 111.67M | 110.8M | 11M | 11.32M | 11.63M | 83.06M | 82.24M | 80.4M | 79.06M | 79.05M | 27.49M | 34.84M | 42.01M |
Common Stock | 159K | 156K | 156K | 155K | 155K | 151K | 151K | 151K | 149K | 146K | 145K | 145K | 145K | 143K | 143K | 143K | 142K |
Retained Earnings | -1.52B | -1.53B | -1.55B | -1.56B | -1.53B | -1.51B | -1.5B | -1.61B | -1.57B | -1.53B | -1.47B | -1.44B | -1.4B | -1.33B | -1.24B | -1.15B | -1.07B |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 |
Shareholders Equity | 237.29M | 222.36M | 192.16M | 177.57M | 160.11M | 160.5M | -1.5B | -1.61B | -1.57B | 58.59M | 100.48M | -1.44B | 170.39M | -1.33B | -1.24B | -1.15B | 445.29M |
Total Investments | 146.01M | 131.91M | 146.34M | 135.29M | 136.92M | 125.86M | 78.26M | 47.9M | 78.24M | 71.78M | 87.85M | 84.71M | 95M | 51.41M | 54.89M | 54.51M | 52.33M |